Thrombotic microangiopathy after kidney transplantation successfully treated with eculizumab: A case report

Thrombotic microangiopathy after kidney transplantation successfully treated with eculizumab: A case report

Background: Transplantation-associated thrombotic microangiopathy (TA-TMA) is relatively rare and may cause graft failure. Atypical hemolytic uremic syndrome (aHUS) is caused by dysregulation of the alternative complement pathway, resulting in TMA. Eculizumab, a humanized anti-C5 monoclonal antibody...

Full description

Bibliographic Details
Main Authors: Tomoko Kawanishi, Jumpei Hasegawa, Momoko Kono, Ayumi Ishiwatari, Toshie Ogawa, Yasutomo Abe, Mariko Endo, Hidetoshi Ishigooka, Masayoshi Okumi, Kazunari Tanabe, Sachiko Wakai, Hiroki Shirakawa
Format: Article
Language:English
Published: Elsevier 2018-06-01
Series:Transplantation Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2451959618300039

Internet

http://www.sciencedirect.com/science/article/pii/S2451959618300039

Similar Items